Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2014 Oct 1;18(5):540.
doi: 10.1186/s13054-014-0540-y.

Is nosocomial infection really the major cause of death in sepsis?

Neil M Goldenberg, Aleksandra Leligdowicz, Arthur S Slutsky, Jan O Friedrich, Warren L Lee
Editorial

Is nosocomial infection really the major cause of death in sepsis?

Neil M Goldenberg et al. Crit Care. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Evidence supporting nosocomial infection as the major cause of death in sepsis is weak. Alternative hypotheses include the role of mitochondrial dysfunction as well as systemic microvascular leak (see text). ARDS, acute respiratory distress syndrome.
See this image and copyright information in PMC

References

    1. Otto GP, Sossdorf M, Claus RA, Rödel J, Menge K, Reinhart K, Bauer M, Riedemann NC: The late phase of sepsis is characterized by an increased microbiological burden and death rate.Crit Care 2011, 15:R183. - PMC - PubMed
    1. Riedemann NC, Guo R-F, Ward PA. Novel strategies for the treatment of sepsis. Nat Med. 2003;9:517–524. doi: 10.1038/nm0503-517. - DOI - PubMed
    1. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013;13:260–268. doi: 10.1016/S1473-3099(13)70001-X. - DOI - PMC - PubMed
    1. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA. 1995;273:934–941. doi: 10.1001/jama.1995.03520360048038. - DOI - PubMed
    1. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987;317:653–658. doi: 10.1056/NEJM198709103171101. - DOI - PubMed

Publication types